Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen - 17/08/11
West Perth, Australia
Abstract |
Background |
There is intense interest in the interaction between microbial compounds and allergy. Although Toll-like receptor (TLR)–2 ligands derived from Gram-positive bacteria alter allergic sensitization in animal models, it is not clear what effect TLR2 ligands have on allergen-specific T-cell memory in human beings.
Objective |
To determine whether in vitro exposure to TLR2 ligands modifies the immune response to house dust mite allergen (HDM).
Methods |
Blood mononuclear cells were obtained from individuals both allergic (n = 23) and not allergic (n = 22) to HDM, and stimulated with HDM in the presence or absence of TLR2 ligands.
Results |
In subjects allergic to HDM, IL-5 and IL-13 responses to HDM were inhibited by heat-killed Staphylococcus aureus, staphylococcal lipoteichoic acid, and the synthetic lipoprotein Pam3CSK4 (P < .005; all stimuli). Although the whole staphylococcal bacteria increased IFN-γ responses, the purified TLR2 ligands lipoteichoic acid and Pam3CSK4 inhibited HDM-specific IFN-γ synthesis. In contrast, TLR2 ligands had minimal effects on responses to HDM in subjects without allergy. TLR2 ligands induced upregulation of HLA-DR expression but did not inhibit antigen uptake or processing by antigen-presenting cells.
Conclusion |
Toll-like receptor 2 ligands inhibit allergen-specific TH2 responses in sensitized individuals. This effect appears to be mediated by the actions of TLR2 ligands on antigen-presenting cells, and at least for the purified TLR2 ligands does not involve the induction of a strong TH1 immune response.
Clinical implications |
These findings provide an impetus for further preclinical studies examining the potential use of TLR2 ligands in allergic disease.
Le texte complet de cet article est disponible en PDF.Key words : Atopy, Toll-like receptors, innate immunity, TH2 cytokines
Abbreviations used : DC, HDM, LTA, MFI, NK, SPT, TLR
Plan
Supported by the National Health and Medical Research Council Australia. Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest. |
Vol 117 - N° 5
P. 1148-1154 - mai 2006 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?